- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/56 - Protease inhibitors from plants
Patent holdings for IPC class A61K 38/56
Total number of patents in this class: 75
10-year publication summary
|
3
|
3
|
9
|
1
|
7
|
4
|
1
|
5
|
8
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Oramed Ltd. | 27 |
16 |
| Entera Bio Ltd. | 50 |
5 |
| The Trustees of the University of Pennsylvania | 4414 |
3 |
| Eli Lilly and Company | 4089 |
3 |
| Hefei Tianhui Biotech Co., Ltd. | 7 |
3 |
| The Regents of the University of California | 20720 |
2 |
| University of Florida Research Foundation, Inc. | 4173 |
2 |
| Medizinische Universitat Wien | 193 |
2 |
| Oramed Pharmaceuticals Inc. | 5 |
2 |
| Universitatsklinikum Freiburg | 58 |
2 |
| University of Maryland, Baltimore | 1066 |
2 |
| Merck Patent GmbH | 5725 |
1 |
| Amgen Inc. | 4425 |
1 |
| Evonik Röhm GmbH | 388 |
1 |
| The Board of Trustees of the Leland Stanford Junior University | 6644 |
1 |
| University of Southern California | 2128 |
1 |
| Adocia | 145 |
1 |
| Anabio Technologies Limited | 34 |
1 |
| Bioprocol Bioprocesos de Colombia S.A.S. | 2 |
1 |
| Cooperatie Avebe U.A. | 79 |
1 |
| Other owners | 24 |